Healthcare Industry News: arthroscopic
News Release - April 29, 2015
CyMedica Orthopedics Launches The QB1 System - A Proprietary Device For Treatment Of Quadriceps Atrophy - At AANA
SCOTTSDALE, Ariz., April 29, 2015 -- (Healthcare Sales & Marketing Network) -- Scottsdale-based CyMedica Orthopedics™, Inc. announced the commercial launch of the CyMedica QB1™ System for the treatment of quadriceps muscle atrophy at the Arthroscopy Association of North American arthroscopic Society for Sports Medicine (AANA) annual meeting in Los Angeles last week. The product was first shown at the AAOS meeting in March.Delivering professional athlete rehabilitation for every patient, the QB1 capitalizes on proprietary revolutionary NMES (neuromuscular electrical stimulation) technology for the treatment of quadriceps muscle atrophy and combines three best-in-class products: a postoperative knee brace, a form-fitting conductive garment, and a user friendly NMES control interface. The device substantially simplifies the delivery of "at home" NMES treatment and encourages patient compliance.
"The CyMedica QB1 knee brace and wrap is a game changer in orthopedics," says Dr. Struan Coleman, CyMedica cofounder, specialist in sports medicine at the Hospital for Special Surgery and NY Mets Head Team Physician. "The QB1 will allow the orthopedic surgeon to treat every patient like a professional athlete by initiating neuromuscular activation immediately following knee surgery. For the first time, the patient, the surgeon and the physical therapist will all be equally involved in postoperative rehabilitation of the knee."
The QB1 NMES system delivers high intensity electrical muscle stimulation while maintaining patient comfort. The QB1's proprietary closed-loop system monitors and adjusts the electrical stimulation power delivered to the patient to ensure consistent and comfortable quadriceps activation.
"We are extremely pleased with the response from surgeons at the AAOS and AANA meetings," said Robert Morocco, President and CEO of CyMedica Orthopedics.
For more information on the CyMedica Orthopedics QB1 please visit www.cymedicaortho.com
About CyMedica Orthopedics, Inc.
Based in Scottsdale, Arizona, CyMedica Orthopedics is a privately held medical device company that develops and commercializes innovative products that target muscle atrophy using its platform technology. That technology includes the first closed-loop power control system to provide patients comfortable yet aggressive treatment.
Source: CyMedica Orthopedics
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!